The study did not observe any clinically relevant association between use of antihypertensive drugs and pancreatic cancer risk in patients with chronic pancreatitis.
Based on a case-crossover analysis, there was an increased risk for acute pancreatitis associated with ongoing methimazole/carbimazole or propylthiouracil treatment.
The study highlights the complexity of patients with necrotizing pancreatitis and the importance of early recognition of possible complications colonic and pleural complications.
Traditional prognostic evaluation methods, ie, TNM staging, do not incorporate certain clinical and socioeconomic factors that impact patient survival.
This study highlights a unique way to assess abdominal pain in patients with chronic pancreatitis; however, the practicality, both for the patient and the physician, may be challenging to incorporate into routine practice.
Black elderberry extract could potentially induce pancreatitis, as described in a recent case report published in the journal Digestive Diseases and Sciences.
Based on the latest developments in diagnostic modalities and a review of current guidelines, including the AGA, The IAP, and the European Study Group on Cystic Tumors of the Pancreas (European), this report discussed recommendations for the diagnosis and management of pancreatic cystic neoplasms (PCN).
The Food and Drug Administration (FDA) has granted Orphan Drug designation to TLY012 (Theraly Fibrosis) for the treatment of chronic pancreatitis.
Rybelsus is the first glucagon-like peptide (GLP-1) available in a tablet formulation that is approved for once daily use.
The researchers discussed the necessity of using a multidisciplinary approach, utilizing a specialized referral center with nutritionists, medical intensivists, procedural radiologists, advanced endoscopists, and pancreatic surgeons who have expertise treating patients with pancreatic necrosis in a multidisciplinary manner.
In a new American Society for Radiation Oncology clinical practice guideline, recommendations are presented for radiation treatment of pancreatic cancer.
Linagliptin is noninferior to glimepiride for adults with relatively early type 2 diabetes and elevated cardiovascular risk.
Using an ELISA model, researchers have confirmed the high sensitivity and specificity of the monoclonal antibody Das-1 in detecting pancreatic cystic lesions (PCLs) with a risk for malignancy.
Peri-procedural aggressive hydration is associated with significantly decreased rates of post-ERCP pancreatitis (PEP) and appears to be a safe and effective strategy for PEP prevention.
Risks for pancreatitis, pancreatic cancer higher in Korean patients with newly diagnosed T2DM
Chronic pancreatitis stems from a variety of pathogenic entities that result in chronic inflammation, fibrosis, and irreversible damage to the pancreas.
In an analysis of pancreatic tissue and cyst fluid samples, researchers identified and validated DNA methylation makers that can detect advanced neoplasia.